Flagship Pioneering as of Sept. 30, 2022
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 12 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 64.1 | $1.5B | 13M | 118.25 | |
| Sana Biotechnology (SANA) | 8.6 | $205M | 34M | 6.00 | |
| Seres Therapeutics | 6.2 | $148M | 23M | 6.42 | |
| Omega Therapeutics (OMGAQ) | 5.9 | $140M | 26M | 5.42 | |
| Foghorn Therapeutics (FHTX) | 4.6 | $109M | 13M | 8.58 | |
| Evelo Biosciences | 4.4 | $105M | 50M | 2.09 | |
| Denali Therapeutics (DNLI) | 3.4 | $80M | 2.6M | 30.69 | |
| Axcella Health Inc equity | 1.4 | $32M | 19M | 1.71 | |
| Rubius Therapeutics | 0.7 | $17M | 39M | 0.43 | |
| Syros Pharmaceuticals (SYRS) | 0.3 | $6.4M | 994k | 6.44 | |
| Sigilon Therapeutics | 0.2 | $5.2M | 10M | 0.50 | |
| Codiak Biosciences | 0.1 | $2.8M | 3.5M | 0.78 |
